The safety and efficacy of neoadjuvant immunochemotherapy following laparoscopic gastrectomy for gastric cancer: a multicentre real-world clinical study.

MLA

Sun, Yu-Qin, et al. “The Safety and Efficacy of Neoadjuvant Immunochemotherapy Following Laparoscopic Gastrectomy for Gastric Cancer: A Multicentre Real-World Clinical Study.” International Journal of Surgery (London, England), vol. 110, no. 8, Aug. 2024, pp. 4830–38. EBSCOhost, https://doi.org/10.1097/JS9.0000000000001468.

APA

Sun, Y.-Q., Zhong, Q., Lv, C.-B., Zhu, J.-Y., Lin, G.-T., Zhang, Z.-Q., Wu, D., Weng, C.-M., Chen, Q.-X., Lian, M.-Q., Zeng, W.-M., Zhang, Y.-B., Chen, Q.-Y., Lin, J.-X., Xie, J.-W., Li, P., Zheng, C.-H., Lu, J., Cai, L.-S., & Huang, C.-M. (2024). The safety and efficacy of neoadjuvant immunochemotherapy following laparoscopic gastrectomy for gastric cancer: a multicentre real-world clinical study. International Journal of Surgery (London, England), 110(8), 4830–4838. https://doi.org/10.1097/JS9.0000000000001468

Chicago

Sun, Yu-Qin, Qing Zhong, Chen-Bin Lv, Ji-Yun Zhu, Guang-Tan Lin, Zhi-Quan Zhang, Dong Wu, et al. 2024. “The Safety and Efficacy of Neoadjuvant Immunochemotherapy Following Laparoscopic Gastrectomy for Gastric Cancer: A Multicentre Real-World Clinical Study.” International Journal of Surgery (London, England) 110 (8): 4830–38. doi:10.1097/JS9.0000000000001468.